GENMAB A/S's ticker is GMAB and the CUSIP is 372303206. A total of 177 filers reported holding GENMAB A/S in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $555,644 | -13.9% | 15,754 | -7.3% | 0.06% | -11.1% |
| Q2 2023 | $645,638 | +3.8% | 16,986 | +3.1% | 0.07% | -2.7% |
| Q1 2023 | $622,209 | -4.6% | 16,478 | +7.1% | 0.07% | -14.0% |
| Q4 2022 | $652,101 | +37.6% | 15,387 | +4.3% | 0.09% | +24.6% |
| Q3 2022 | $474,000 | +34.3% | 14,750 | +35.8% | 0.07% | +40.8% |
| Q2 2022 | $353,000 | -3.0% | 10,863 | +8.0% | 0.05% | +11.4% |
| Q1 2022 | $364,000 | +32.4% | 10,054 | +44.7% | 0.04% | +22.2% |
| Q4 2021 | $275,000 | -10.1% | 6,950 | -0.7% | 0.04% | -16.3% |
| Q3 2021 | $306,000 | +19.5% | 7,001 | +11.8% | 0.04% | +13.2% |
| Q2 2021 | $256,000 | +509.5% | 6,263 | +504.5% | 0.04% | +245.5% |
| Q4 2020 | $42,000 | – | 1,036 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 242,848 | $9,169,940 | 3.80% |
| Capricorn Fund Managers Ltd | 110,643 | $4,177,880 | 1.28% |
| Arlington Capital Management, Inc. | 35,591 | $1,343,916 | 1.26% |
| XY Capital Ltd | 76,884 | $2,903,140 | 1.13% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 88,000 | $3,322,880 | 0.93% |
| TORRAY INVESTMENT PARTNERS LLC | 110,807 | $4,184,072 | 0.75% |
| Hardman Johnston Global Advisors LLC | 585,139 | $22,094,849 | 0.72% |
| Yorktown Management & Research Co Inc | 16,600 | $626,816 | 0.68% |
| First Light Asset Management, LLC | 160,025 | $6,042,544 | 0.54% |
| MIRABELLA FINANCIAL SERVICES LLP | 28,260 | $2,505,855 | 0.38% |